All In Biotech

Drug Trial Radar · NCT01552902

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)

Last checked: Nov 19, 2026Latest source record: Jun 10, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 549 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

549

Actual

Start

Apr 3, 2012

Primary completion

May 22, 2014

Study completion May 22, 2014

Sponsor

Lead sponsor
ShireTakeda (TAK)
Sponsor type
Industry
First posted
Mar 13, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 13 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine effectiveness of Vyvanse compared to Concerta in adolescents with Attention-deficit/Hyperactivity Disorder (ADHD).

Conditions

  • Attention-deficit/Hyperactivity Disorder

Interventions

  • Lisdexamfetamine dimesylateDrug

    Daily oral dosing in the AM ranging from 30- 70 mg. 4 week forced dose titration, 2 week dose maintenance

  • Methylphenidate HydrochlorideDrug

    Daily oral dosing in the AM ranging from 18-72 mg. 4 week force dose titration, 2 week dose maintenance

  • PlaceboDrug

    Daily oral dosing in the AM for 6 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) Total Score at Week 6Time frame: Baseline, Week 6

Locations

95 sites in 5 countries. Site status is shown where the registry gives one.

  • Harmonex Neuroscience Research, Inc.

    Dothan, Alabama

  • Center for Advanced Improvement

    Tucson, Arizona

  • Clinical Study Centers, LLC

    Little Rock, Arkansas

  • Shanti Clinical Trials

    Colton, California

  • Sun Valley Research Center

    Imperial, California

  • Synergy Clinical Research Center

    National City, California

  • Pacific Sleep Medicine, A Medical Corporation

    Oceanside, California

  • Neuropsychiatric Research Center for Orange County

    Orange, California

  • Peninsula Research Associates

    Rolling Hills Estates, California

  • PCSD - Feighner Research

    San Diego, California

  • University of California, San Francisco

    San Francisco, California

  • Encompass Clinical Research

    Spring Valley, California

  • Elite Clinical Trials

    Wildomar, California

  • IMMUNOe International Research Center

    Centennial, Colorado

  • MCB Clinical Research Centers, LLC

    Colorado Springs, Colorado

  • Coastal Connecticut Research, LLC

    New London, Connecticut

  • Florida Clinical Research Center, LLC

    Bradenton, Florida

  • Amedica Research Institute, Inc

    Hialeah, Florida

  • Clinical Neuroscience Solutions, Inc

    Jacksonville, Florida

  • Sarkis Clinical Trials

    Lake City, Florida

  • Florida Clinical Research Center, LLC

    Maitland, Florida

  • Prevention & Strengthening Solutions, Inc.

    Miami, Florida

  • Scientific Clinical Research, Inc.

    North Miami, Florida

  • Medical Research Group of Central Florida

    Orange City, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • Compass Research, LLC

    Orlando, Florida

  • Miami Research Associates

    South Miami, Florida

  • Stedman Clinical Trials

    Tampa, Florida

  • Atlanta Institute of Medicine & Research, Inc

    Atlanta, Georgia

  • Clinical Research Center, University of Illinois at Chicago

    Chicago, Illinois

  • Capstone Clinical Research

    Libertyville, Illinois

  • Baber Research Group

    Naperville, Illinois

  • Pedia Research, LLC

    Newburgh, Indiana

  • Psychiatric Associates

    Overland Park, Kansas

  • Pedia Research, LLC

    Owensboro, Kentucky

  • Louisiana Resarch Associates, Inc.

    New Orleans, Louisiana

  • Marc Hertzman, MD, PC

    Rockville, Maryland

  • Rochester Center for Behavioral Medicine

    Rochester Hills, Michigan

  • Clinical Neurophysiology Services, PC

    Sterling Heights, Michigan

  • Behavioral Medical Center - Troy

    Troy, Michigan

Showing 40 of 95 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.